Physician profile
Steven Speaker
NPI 1063883965
$3,095.35
in general payments reported to CMS, 2019-2025
8 companies · $204 in 2025
The $204 reported for 2025 was more than what 76% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.85 · 2020: $234 · 2021: $748 · 2022: $95.87 · 2023: $1,450 · 2024: $296 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $694 · Consulting Fee: $150 · Gift: $4.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.63 |
| Travel and Lodging | $693.70 |
| Consulting Fee | $150.00 |
| Gift | $4.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,709.49 | 2020-2025 | Invisalign, Itero, Itero Element 5d Plus Lite |
| Ormco Corporation | $776.06 | 2020-2021 | |
| American Orthodontics Corporation | $472.25 | 2019-2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
| Patterson Companies, INC. | $44.23 | 2022 | |
| Biohorizons Implant Systems INC. | $38.09 | 2023 | Biohorizons |
| Kulzer, LLC | $26.04 | 2020 | |
| 3m Company | $18.48 | 2022 | |
| USA Angelalign Technology Corp | $10.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Speaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.